Objective: We compared surgical resection (SR) and radiofrequency ablation (RFA) as first-
line treatment in patients with hepatocellular carcinoma (HCC) based on the risk of …

Radiofrequency ablation (RFA) has emerged as an effective loco-regional treatment
modality for malignant hepatic tumors. Indeed, studies have demonstrated that RFA of early …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide.
Curative treatments for early-stage HCC include local ablation, hepatic resection, and liver …

Purpose To compare the long-term therapeutic outcomes of radiofrequency (RF) ablation for
hepatocellular carcinoma (HCC) in subcapsular versus nonsubcapsular locations by using …

Objectives Recurrence rate is up to 70% at 5 years for hepatocellular carcinoma (HCC) after
initial resection, but the management of recurrent HCC remains unclear. To compare the …

Objectives To evaluate the therapeutic efficacy of and vascular complications associated
with percutaneous cryoablation for the treatment of perivascular HCC. Methods Between …

Biopsies of liver masses that prove to be hepatocellular carcinomas (HCCs) are associated
with a risk of seeding the abdominal or chest wall with tumor cells. The reported frequency of …

Purpose The percutaneous ablation of subcapsular hepatocellular carcinoma (S-HCC) may
involve a risk of complications such as hemorrhage and tumor seeding, mainly linked to the …

Objectives To compare the efficacy and safety of ultrasound (US) and computed tomography
(CT) in the guidance of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) …

Purpose To investigate the outcomes of radiofrequency ablation (RFA) following artificial
ascites (AA) and artificial pleural effusion (AP) creation for hepatocellular carcinoma (HCC) …